Novartis’ rare renal disease candidate shows promise in phase II
Investigational oral treatment is being investigated in C3 glomerulopathy
Read More
Tag: ASN 2020
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
Read More
- Pulsesight reports positive phase 1 data for PST‑611 in dry AMD
- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
